reports
Moody's Ratings assigns Baa1 to Keurig Dr Pepper's notes, outlook is s...
Moody's Ratings (Moody's) today assigned a Baa1 rating to Keurig Dr Pepper Inc.'s ("KDP") new senior unsecured notes to be issue in multiple tranches. All other ratings for the company including the Baa1 senior unsecured rating and Prime-2 commercial paper (CP) rating remain unchanged. The rating ou...
Cidara Therapeutics to Report First Quarter 2025 Financial Results and...
Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its first quarter 2025 financial results and operational highlights after the close of the U.S. financial markets on Thursday, May 8, 2025. The Company will host a conference call and webcast at 5:00 PM Eastern Time to discus...
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule...
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human Capital Committee of its Board of Directors (Compensation Committee) granted Timothy Alefantis, a new employee, a non-qualified stock option award and restricted stock units (RSUs) for an aggregate of 27,000 shares of its common stock, pursuant to the Cidara...
Cidara Therapeutics to Participate in the 24th Annual Needham Virtual ...
Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that company management will participate in the 24th Annual Needham Virtual Healthcare Conference. Details are as follows: Event: 24th Annual Needham Virtual Healthcare ConferenceDate: Wednesday, April 9, 2025Time: 11:00 AM ET Format: Presentation Webcast: A replay of the pre...
Fuel Tech Awarded Air Pollution Control Orders Totaling $1.4 Million
Fuel Tech Awarded Air Pollution Control Orders Totaling $1.4 Million WARRENVILLE, Ill., March 27, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced the receipt of air pollution control (APC) orders from new and existing customers in the US and Europe. These orders have an aggregate value of approximately $1.4 million. A contract was received from a new customer in the US for an ULTRA® system to ...
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.6 Million
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.6 Million WARRENVILLE, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced the receipt of air pollution control (APC) orders from existing customers in the US and Japan. These orders have an aggregate value of approximately $2.6 million. An order from Japan was received for an ULTRA® system that will be installed on a nat...
Cidara Therapeutics to Participate in World Health Organization Meetin...
Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced participation in the “Other pharmaceuticals as preventive tools” panel at a World Health Organization (WHO) global meeting on H5N1 influenza preparedness and response. The meeting, titled “What research is important to prepare and respond to H5N1 influenza...
Cidara Therapeutics Announces Two Presentations on CD388 in Influenza ...
Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025 SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming presentations at the 38th International Conference on Antiviral Research (ICAR). The conference takes place from March 17-21, 2025 in Las Vegas, Nevada. Cidara’s presentations will highlight the study design, demographic inform...
Cidara Therapeutics Announces Publication of CD388 Preclinical Data in...
Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune status SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced the publication of preclinical data assessing CD388, the company’s influenza DFC, in the peer-reviewed scientific journal Nature Microbiology. The article, ent...
- Jonathan Moreland
HSII HEIDRICK & STRUGGLES INTERNATIONAL INC.
EVH
CE EVOLENT HEALTH INC CLASS A
CDXS CELANESE CORPORATION
APPS CODEXIS
AAP DIGITAL TURBINE
MEDP ADVANCE AUTO PARTS INC.
FSLR MEDPACE HOLDINGS INC.
NSA FIRST SOLAR INC.
CLF NATIONAL STORAGE AFFILIATES TRUST
RCII CLIFFS NATURAL RESOURCES INC.
STXS RENT-A-CENTER INC
GRX STEREOTAXIS
AMPY THE GABELLI HEALTHCARE & WELLNESSRX TRUST
RC AMPLIFY ENERGY
ACA GRUPO RADIO CENTRO S.A.B. DE C.V.
ENX ARCOSA
BIGC EATON VANCE NEW YORK MUNICIPAL BOND FUND
CZR BIGCOMMERCE HOLDINGS
NOG INC.
PRDO CAESARS ENTERTAINMENT INC
ABCL NORTHERN OIL AND GAS
UAN PERDOCEO EDUCATION CORP
INDI ABCELLERA BIOLOGICS
IE CVR PARTNERS LP
ECAT INDIE SEMICONDUCTOR INC
MEGI IVANHOE ELECTRIC INC
RCEL BLACKROCK ESG CAP ALLOCATION TR
SBGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
TKO AVITA MEDICAL INC
CUBA SINCLAIR INC
BHRB TKO GROUP HOLDINGS
GAM INC.
SUNS THE HERZFELD CARIBBEAN BASIN FUND
GF INC.
BURKE HERBERT FINANCIAL SERVICES CORP
GENERAL DE ALQUILER DE MAQUINARIA
SUNRISE REALTY TRUST
THE NEW GERMANY FUND
INC.
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quart...
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results Completed enrollment of 5,000 subject Phase 2b NAVIGATE trialSevere flu season enables potential mid-year assessment of efficacyClosed $105.0 million financing with new and existing investorsSignificantly expanded equity research coverage SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today reported f...
Fuel Tech Reports 2024 Fourth Quarter and Full Year Financial Results
Fuel Tech Reports 2024 Fourth Quarter and Full Year Financial Results WARRENVILLE, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported financial results for the fourth quarter (Q4) and full year ended December 31, 2024. “Revenues for full year 2024 came in at the lower end of our guidance range of $25 million to $26 million, due primarily to the impact of delayed project execution and to...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
AMN AMN HEALTHCARE SERVICES INC.
TSN TYSON FOODS INC. CLASS A
PNM PNM RESOURCES INC.
OGE OGE ENERGY CORP.
MNST MONSTER BEVERAGE CORPORATION
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
LNT ALLIANT ENERGY CORP
KHC KRAFT HEINZ COMPANY
HSY HERSHEY COMPANY
GIS GENERAL MILLS INC.
FE FIRSTENERGY CORP.
ED CONSOLIDATED EDISON INC.
DUK DUKE ENERGY CORPORATION
D DOMINION ENERGY INC
CPB CAMPBELL SOUP COMPANY
CAG CONAGRA BRANDS INC.
GASS STEALTHGAS
SJM J.M. SMUCKER COMPANY
IRTC IRHYTHM TECHNOLOGIES INC.
NOMDN NOMAD FOODS LTD.
SOI SOLARIS OILFIELD INFRASTRUCTURE
CELH CELSIUS HOLDINGS INC.
KDP KEURIG DR PEPPER INC.
CWAN CLEARWATER ANALYTICS HLDGS INC
KVUE KENVUE INC
WAY WAYSTAR HOLDING CORP
PRMB PRIMO BRANDS CORP
Fuel Tech Schedules 2024 Fourth Quarter and Full Year Financial Result...
Fuel Tech Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call WARRENVILLE, Ill., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, March 4, 2025 after the close of the stock market. Management will host a conference call on Wednesday, March 5, 2025 a...
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Fina...
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer Industry veteran CFO Frank Karbe brings more than 25 years of leadership experience in the biopharma industry transitioning companies from R&D to commercialization SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that Frank Karbe, MBA, has bee...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Keurig Dr Pepper Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 14 February 2025 in which we reassessed the appropriateness of the ratings in the con...
Fuel Tech Awarded Air Pollution Control Orders Totaling $1.6 Million
Fuel Tech Awarded Air Pollution Control Orders Totaling $1.6 Million Expects to Close New Awards Valued at $4 Million to $5 Million WARRENVILLE, Ill., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced the receipt of air pollution control (APC) orders from new and existing customers in the US. These orders have an aggregate value of approximately $1.6 million. A contract was received from...
Cidara Therapeutics to Participate in the Guggenheim Securities SMID C...
Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will participate in the Guggenheim Securities SMID Cap Biotech Conference. Details are as follows: Event: Guggenheim Sec...
Fuel Tech to Showcase DGI® Dissolved Gas Infusion Technology at Aquacu...
Fuel Tech to Showcase DGI® Dissolved Gas Infusion Technology at Aquaculture 2025 in New Orleans WARRENVILLE, Ill., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced that it will exhibit its DGI® Dissolved Gas Infusion technology at Aquaculture 2025 being held in New Orleans March 6-10, 2025. Fuel Tech representatives will be at Booth 334. Held every three years and known as the Triennial, th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.